People vaccinated with two doses of Pfizer or Moderna have a 94% chance of not being hospitalized for COVID-19



[ad_1]

Vials of COVID-19 vaccine from Pfizer-BioNTech and Moderna, March 19, 2021. REUTERS / Dado Ruvic /
Vials of COVID-19 vaccine from Pfizer-BioNTech and Moderna, March 19, 2021. REUTERS / Dado Ruvic /

The Centers for Disease Control of the United States (CDC, for its acronym in English), published on Wednesday a study concluding that Those who have been vaccinated with two doses of the Pfizer or Moderna COVID-19 vaccines – the two most used in the North American country – have a 94% chance of not being hospitalized as a result of the disease.

The percentage among those who received a dose was 64% for people over 65, who are more at risk for severe symptoms.

The study is based on the results of clinical trials on 417 adults hospitalized in 14 states of the United States between the months of January to March.

Vaccination is on the rise in the United States.  EFE / Rodrigo Jiménez / Archives
Vaccination is on the rise in the United States. EFE / Rodrigo Jiménez / Archives

“This assessment carried out with real information from several different parts of the country suggests that vaccination provided protection against hospitalization associated with COVID-19 in adults [65 años o más]”, the states of the study.

The virus is particularly dangerous for the elderly, the results in this age group are therefore particularly important.

The 94% efficacy rate was for fully vaccinated people, which means that they had switched toAt least two weeks after your second dose.

File image of Johnson & Johnson COVID-19 vaccine boxes at the McKesson Corporation, amid the coronavirus pandemic, in Shepherdsville, United States.  March 1, 2021. Timothy D. Easley / Pool via REUTERS / Archive
File image of Johnson & Johnson COVID-19 vaccine boxes at the McKesson Corporation, amid the coronavirus pandemic, in Shepherdsville, United States. March 1, 2021. Timothy D. Easley / Pool via REUTERS / Archive

For people who were only partially vaccinated, which means it was more than two weeks after the first dose but less than two weeks after the second dose, the effectiveness against hospitalizations was 64 percent.

In particular, vaccination was not significantly effective in people infected less than 14 days after their first dose, showing that protection takes time, and people should not immediately ignore precautions.

The results show that as vaccines become more widespread, hospitalizations and deaths will decrease, said the CDC.

“These data suggest that Continuing to rapidly vaccinate American adults against COVID-19 will likely have a marked impact on hospitalization of COVID-19 and could lead to commensurate reductions in post-COVID conditions and deaths, ”the study says.

The United States has so far administered only 8 million Johnson & Johnson vaccines, compared to more than 118 million units from Pfizer.  EFE / Etienne Laurent / Archives
The United States has so far administered only 8 million Johnson & Johnson vaccines, compared to more than 118 million units from Pfizer. EFE / Etienne Laurent / Archives

As the vaccination campaign progresses, COVID-19 deaths have fallen dramatically, from January highs of more than 3,000 per day at about 650 a day today, according to CDC data.

On Wednesday, the World Health Organization (WHO) said that no country should let its guard down even if the vaccination of its population against covid-19 is progressing well and it calls on all to maintain essential preventive measures, such as the use of masks, hand hygiene, and avoiding mass gatherings.

“People who have been vaccinated should continue with the measurements especially when interacting outside of your family circle, wear masks, clean your hands and avoid attending mass events. We don’t want a new wave of pandemic, let’s not forget what happened even in countries where vaccination campaigns are successful, ”said WHO vaccine officer Kate O ‘Brien.

KEEP READING:

A single dose of AstraZeneca or Pfizer vaccines would halve the spread of the coronavirus
Calls and SMS: How the European Union came to an agreement with Pfizer to buy 1.8 billion doses



[ad_2]
Source link